The bankruptcy underscores the great risks of investing in many of the companies that have gone public via mergers with ...

Today the market is a SPAC graveyard—with genetics testing startup 23andMe the latest casualty after declaring Chapter 11 bankruptcy late Sunday night. According to new data from the financial ...

Several state attorneys general (AGs) and the Federal Trade Commission (FTC) have begun scrutinizing ancestry tracking company 23andMe following ...

In a significant turn of events, the genetic testing company 23andMe announced its filing for Chapter 11 bankruptcy protection on Sunday, marking a profound shift in its operations and strategy. This ...

Data hacks, a class action lawsuit, and leadership tension between Wojcicki and the board have left 23andMe's fate in the balance as it searches for a buyer. Many have expressed concern a takeover ...

23andMe bankruptcy underscores the risk of investing in most SPACs. - MarketWatch photo illustration/iStockphoto 23andMe is going bankrupt — underscoring the great ...

There is a federal law, the Genetic Information Nondiscrimination Act (GINA) of 2008, that is supposed to protect Americans ...

Mergers with SPACs have been a way for companies to get public-market listings without the heavy scrutiny of the IPO process 23andMe is going bankrupt - underscoring the great risks of investing ...